carbapenems has been researched along with gold in 2 studies
| Studies (carbapenems) | Trials (carbapenems) | Recent Studies (post-2010) (carbapenems) | Studies (gold) | Trials (gold) | Recent Studies (post-2010) (gold) |
|---|---|---|---|---|---|
| 7,355 | 147 | 5,277 | 47,670 | 302 | 31,345 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Shaaban, MI; Shaker, MA | 1 |
| Dai, P; Feng, J; Hu, D; Li, P; Lin, R; Luo, X; Mu, K; Xu, M; Yu, L; Zhang, J; Zheng, C | 1 |
2 other study(ies) available for carbapenems and gold
| Article | Year |
|---|---|
Formulation of carbapenems loaded gold nanoparticles to combat multi-antibiotic bacterial resistance: In vitro antibacterial study.
Topics: Anti-Bacterial Agents; Carbapenems; Gold; Imipenem; Metal Nanoparticles; Microbial Sensitivity Tests; Thienamycins | 2017 |
Emergence of Extensively Drug-Resistant ST170 Citrobacter portucalensis with Plasmids pK218-KPC, pK218-NDM, and pK218-SHV from a Tertiary Hospital, China.
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Gold; Humans; Klebsiella pneumoniae; Microbial Sensitivity Tests; Plasmids; Tertiary Care Centers | 2022 |